Meds Entry Watch – PMPRB’s new annual publication

High-priced specialized drugs were at the top of the newly marketed drug list, and they also led new drug sales on the international market in 2015

As part of a series of reports designed to inform decision makers, researchers and patients of the evolving market dynamics associated with emerging drug therapies, the first edition of the Meds Entry Watch, 2015 was recently published by the Patented Medicine Prices Review Board (PMPRB) within the scope of a research initiative of the National Prescription Drug Utilization Information System (NPDUIS).

Some of the highlights:

  • A reference analysis of international availability
  • A launch schedule
  • Market penetration
  • Sales and prices of new drugs launched on the Canadian market and other international markets between 2009 and 2014
  • A preliminary analysis of drugs launched in 2015